Cardiovascular Health (CVH) metrics scores are associated with cardiovascular disease but whether CVH scores are associated with nonalcoholic fatty liver disease (NAFLD) is uncertain. Our aim was to investigate associations between CVH scores and development or regression of NAFLD. A cohort study was performed in Korean adults who underwent a comprehensive health examination. The CVH metrics were defined according to the American Heart Association Life’s Simple 7 metrics, ranging from 0 (all metrics considered unhealthy) to 7 (all metrics considered healthy). Fatty liver was diagnosed by ultrasound, and liver fibrosis assessed using NAFLD fibrosis score (NFS). Among 93,500 participants without NAFLD or fibrosis at baseline, 15,899 dev...
BACKGROUND: Studies have reported a significant association between non-alcoholic fatty liver diseas...
Background: Cardiovascular-related mortality is a major concern in NAFLD. Advanced fibrosis was know...
Background: The fatty liver index (FLI) and the hepatic steatosis index (HSI), are biomarker-based a...
Cardiovascular Health (CVH) metrics scores are associated with cardiovascular disease but whether CV...
Abstract Background The association between cardiovascular risk factors and nonalcoholic fatty liver...
This study aimed to determine whether nonalcoholic fatty liver disease (NAFLD) is an independent ris...
Fatty liver index (FLI) is a simple and useful index that evaluates non-alcoholic fatty liver diseas...
BackgroundWe investigated the association between the severity of non-alcoholic fatty liver disease ...
Background & Aims We compared the associations of nonalcoholic fatty liver disease (NAFLD) and alcoh...
BackgroundCardiovascular disease (CVD) risk is higher in patients with nonalcoholic fatty liver dise...
Cardiovascular disease (CVD) is the leading cause of mortality among adults with nonalcoholic fatty ...
Background: The American Heart Association (AHA) has defined Life\u27s Simple 7 (LS7) as a measure o...
Background: The fatty liver index (FLI) and the hepatic steatosis index (HSI), are biomarker-based a...
BACKGROUND & AIMS: Patients with non-alcoholic fatty liver disease (NAFLD) are at increased chan...
Background and aim: Nonalcoholic fatty liver (NAFL) is a major cause of liver disease worldwide lea...
BACKGROUND: Studies have reported a significant association between non-alcoholic fatty liver diseas...
Background: Cardiovascular-related mortality is a major concern in NAFLD. Advanced fibrosis was know...
Background: The fatty liver index (FLI) and the hepatic steatosis index (HSI), are biomarker-based a...
Cardiovascular Health (CVH) metrics scores are associated with cardiovascular disease but whether CV...
Abstract Background The association between cardiovascular risk factors and nonalcoholic fatty liver...
This study aimed to determine whether nonalcoholic fatty liver disease (NAFLD) is an independent ris...
Fatty liver index (FLI) is a simple and useful index that evaluates non-alcoholic fatty liver diseas...
BackgroundWe investigated the association between the severity of non-alcoholic fatty liver disease ...
Background & Aims We compared the associations of nonalcoholic fatty liver disease (NAFLD) and alcoh...
BackgroundCardiovascular disease (CVD) risk is higher in patients with nonalcoholic fatty liver dise...
Cardiovascular disease (CVD) is the leading cause of mortality among adults with nonalcoholic fatty ...
Background: The American Heart Association (AHA) has defined Life\u27s Simple 7 (LS7) as a measure o...
Background: The fatty liver index (FLI) and the hepatic steatosis index (HSI), are biomarker-based a...
BACKGROUND & AIMS: Patients with non-alcoholic fatty liver disease (NAFLD) are at increased chan...
Background and aim: Nonalcoholic fatty liver (NAFL) is a major cause of liver disease worldwide lea...
BACKGROUND: Studies have reported a significant association between non-alcoholic fatty liver diseas...
Background: Cardiovascular-related mortality is a major concern in NAFLD. Advanced fibrosis was know...
Background: The fatty liver index (FLI) and the hepatic steatosis index (HSI), are biomarker-based a...